APA (7th ed.) Citation

C, W., X, G., X, C., R, R., L, J., Z, S., . . . Y, Z. (2026). Immunotherapy-based adjuvant treatment after neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma according to pathological response. Frontiers in immunology, 17, 1802037. https://doi.org/10.3389/fimmu.2026.1802037

Chicago Style (17th ed.) Citation

C, Wang, Geng X, Cheng X, Ren R, Jin L, Sheng Z, Li S, Zang M, and Zhang Y. "Immunotherapy-based Adjuvant Treatment After Neoadjuvant Immunochemotherapy in Esophageal Squamous Cell Carcinoma According to Pathological Response." Frontiers in Immunology 17 (2026): 1802037. https://doi.org/10.3389/fimmu.2026.1802037.

MLA (9th ed.) Citation

C, Wang, et al. "Immunotherapy-based Adjuvant Treatment After Neoadjuvant Immunochemotherapy in Esophageal Squamous Cell Carcinoma According to Pathological Response." Frontiers in Immunology, vol. 17, 2026, p. 1802037, https://doi.org/10.3389/fimmu.2026.1802037.